fulvestrant has been researched along with etonogestrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hussar, D | 1 |
1 review(s) available for fulvestrant and etonogestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fulvestrant and etonogestrel
| Article | Year |
|---|---|
New drugs 2003, part II.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds | 2003 |